ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Illinois » Internal Medicine

Top Internal Medicine Prescribers in Illinois

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MICHEL GOWHARI D.O.

Internal Medicine

516

$61.7K

67
0 are 65+

52%
patients receiving schedule two controlled substances

Avg: 1%

40%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$120
Average prescription price

Avg: $60

THOMAS ALBERT D.C., M.D.

Internal Medicine

514

$25.9K

67
52 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $60

BRYAN MCVAY D.O.

Internal Medicine

512

$192K

89
66 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

71%
prescriptions for brand name drugs

Avg: 25%

$375
Average prescription price

Avg: $60

HILTON GORDON MD

Internal Medicine

510

$8,009

159
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

88%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

4%
prescriptions for brand name drugs

Avg: 25%

$16
Average prescription price

Avg: $60

FARIBA JAVADI M.D.

Internal Medicine

503

$108K

69
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 25%

$215
Average prescription price

Avg: $60

ROBERT DIETER MD

Internal Medicine

493

$42.1K

45
39 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 25%

$85
Average prescription price

Avg: $60

ANDREA SLASURAITIS MD

Internal Medicine

491

$21.2K

42
26 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$43
Average prescription price

Avg: $60

ALEX ULITSKY MD

Internal Medicine

482

$50.4K

137
85 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 25%

$105
Average prescription price

Avg: $60

JACK PINTO MD

Internal Medicine

473

$39.2K

80
70 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$83
Average prescription price

Avg: $60

MAISARA KOBAISY M.D.

Internal Medicine

457

$22.5K

34
16 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$49
Average prescription price

Avg: $60

JAMAL ROSS M.D.

Internal Medicine

456

$24.5K

37
15 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $60

PRASUN DAS MD

Internal Medicine

435

$8,910

321
276 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

9%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

10%
prescriptions for brand name drugs

Avg: 25%

$20
Average prescription price

Avg: $60

ILAXI PATEL D.O.

Internal Medicine

419

$7,841

283
215 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

8%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 25%

$19
Average prescription price

Avg: $60

ERIC STERN MD

Internal Medicine

416

$74.7K

99
79 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

58%
prescriptions for brand name drugs

Avg: 25%

$180
Average prescription price

Avg: $60

MENSUR SUNJE M.D. M.SC.

Internal Medicine

414

$4,513

134
50 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

62%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

4%
prescriptions for brand name drugs

Avg: 25%

$11
Average prescription price

Avg: $60

ASHISH ARORA MD

Internal Medicine

414

$299K

101
62 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 25%

$723
Average prescription price

Avg: $60

TRUSHIL SHAH M.D.

Internal Medicine

412

$9,533

34
24 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 25%

$23
Average prescription price

Avg: $60

CAROLYN TRELKA-ROJAS M.D.

Internal Medicine

395

$7,905

27
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

8%
prescriptions for brand name drugs

Avg: 25%

$20
Average prescription price

Avg: $60

SWAPNA RAO M.D.

Internal Medicine

385

$68.6K

74
39 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$178
Average prescription price

Avg: $60

BRIAN HUGHES M.D.

Internal Medicine

384

$6,012

229
142 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

30%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

10%
prescriptions for brand name drugs

Avg: 25%

$16
Average prescription price

Avg: $60

ASMA FATIMA M.D.

Internal Medicine

365

$16.6K

107
55 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

32%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$46
Average prescription price

Avg: $60

SAM GAINES M.D.

Internal Medicine

346

$4,666

213
90 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

44%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

9%
prescriptions for brand name drugs

Avg: 25%

$13
Average prescription price

Avg: $60

WORLALI NUTAKOR M.D.

Internal Medicine

344

$4,507

226
124 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

26%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

6%
prescriptions for brand name drugs

Avg: 25%

$13
Average prescription price

Avg: $60

OMAR KHOKHAR MD

Internal Medicine

344

$36.6K

144
105 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 25%

$106
Average prescription price

Avg: $60

BHAVEN SHAH MD

Internal Medicine

342

$45K

73
64 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

63%
prescriptions for brand name drugs

Avg: 25%

$132
Average prescription price

Avg: $60

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank